Ledipasvir and Sofosbuvir 90 mg/1
Ledipasvir and Sofosbuvir · TABLET, FILM COATED · Asegua Therapeutics LLC
No Recall History
Plain English
Ledipasvir and Sofosbuvir is a tablet, film coated containing ledipasvir and sofosbuvir at 90 mg/1, taken oral. Manufactured by Asegua Therapeutics LLC.
Key Facts
- Brand Name
- Ledipasvir and Sofosbuvir
- Generic Name
- Ledipasvir and Sofosbuvir
- NDC Code (Product)
72626-2601- Manufacturer
- Asegua Therapeutics LLC
- Strength
- 90 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA205834
- Drug Class
- Hepatitis C Virus NS5A Inhibitor [EPC]; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
- Marketing Start
- 01/01/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Ledipasvir and Sofosbuvir used for?
Ledipasvir and Sofosbuvir contains Ledipasvir and Sofosbuvir. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Ledipasvir and Sofosbuvir a controlled substance?
Ledipasvir and Sofosbuvir is not classified as a controlled substance by the DEA.
What is the generic name for Ledipasvir and Sofosbuvir?
The generic name for Ledipasvir and Sofosbuvir is Ledipasvir and Sofosbuvir. There are 4 other brand versions of Ledipasvir and Sofosbuvir.
What is the NDC code for Ledipasvir and Sofosbuvir 90 mg/1?
The NDC (National Drug Code) for Ledipasvir and Sofosbuvir 90 mg/1 is 72626-2601, listed by Asegua Therapeutics LLC.